Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacodynamic
Interventions
DRUG:
Nalmefene hydrochloride
DRUG:
Naloxone hydrochloride
Sponsor
Opiant Pharmaceuticals Inc